Vitrectomy in Diabetic Macular Edema

Vitrectomy in Diabetic Macular Edema

Purpose: The foveal avascular zone (FAZ) has been reported to decrease after anti-VEGF injections in diabetic macular edema (DME) in the long term. This study aimed to present the changes in swept-source OCT angiography after vitrectomy in patients with DME. Design: Retrospective interventional stud...

Full description

Bibliographic Details
Main Authors:	Zofia Anna Nawrocka, MD, PhD, Jerzy Nawrocki, MD, PhD
Format:	Article
Language:	English
Published:	Elsevier 2022-12-01
Series:	Ophthalmology Science
Subjects:	Diabetic macular edema DME Swept-source OCT angiography Vitrectomy Anti-VEGF injections
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666914522000963

Similar Items

Bibliometric and visualized analysis of diabetic macular edema
by: Jin Wei, et al.
Published: (2024-01-01)

Evaluation of efficacy dexamethasone intravitreal implant compared to treatment with anti-VEGF in the treatment of diabetic macular edema
by: Elena Pacella, et al.
Published: (2014-12-01)

Aflibercept versus Faricimab in the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Review
by: Sławomir Liberski, et al.
Published: (2022-08-01)

Hyperreflective Foci and Subretinal Fluid Are Potential Imaging Biomarkers to Evaluate Anti-VEGF Effect in Diabetic Macular Edema
by: Shiyue Qin, et al.
Published: (2021-12-01)

One-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema
by: Tran THC, et al.
Published: (2021-05-01)

Predicting visual outcomes following anti-vascular endothelial growth factor treatment for diabetic macular edema
by: Vipin Rana, et al.
Published: (2024-01-01)

Optimizing treatment for diabetic macular edema during cataract surgery
by: Leo Ka Yu Chan, et al.
Published: (2023-01-01)

Computational Imaging Biomarker Correlation with Intraocular Cytokine Expression in Diabetic Macular Edema
by: Sudeshna Sil Kar, PhD, et al.
Published: (2022-06-01)

Characterizing Macular Neovascularization in Myopic Macular Degeneration and Age-Related Macular Degeneration Using Swept Source OCTA
by: Sayah DN, et al.
Published: (2023-12-01)

25G pars plana vitrectomy combined with Dexamethasone intravitreal implants for the treatment of vitreous hemorrhage and diabetic macular edema secondary to proliferative diabetic retinopathy
by: Xiao-Ling Jiao, et al.
Published: (2023-10-01)

Multi-Compartment Spatially-Derived Radiomics From Optical Coherence Tomography Predict Anti-VEGF Treatment Durability in Macular Edema Secondary to Retinal Vascular Disease: Preliminary Findings
by: Sudeshna Sil Kar, et al.
Published: (2021-01-01)

Functional results one-year following the anti-VEGF therapy in macular pathology
by: Nicoleta Anton, et al.
Published: (2023-12-01)

Role of Vitrectomy in Nontractional Refractory Diabetic Macular Edema
by: Stefano Ranno, et al.
Published: (2023-03-01)

Efficacy and Safety of Subthreshold Micropulse Yellow Laser for Persistent Diabetic Macular Edema After Vitrectomy: A Pilot Study
by: Vincenza Bonfiglio, et al.
Published: (2022-04-01)

Visual and anatomic outcomes of sustained single agent anti-VEGF treatment versus double anti-VEGF switching in the treatment of persistent diabetic macular edema
by: Osama A. Sorour, et al.
Published: (2020-06-01)

Influence of Intravitreal Therapy on Choroidal Thickness in Patients with Diabetic Macular Edema
by: Patricia Udaondo Mirete, et al.
Published: (2023-01-01)

Vitrectomy for center-involved diabetic macular edema
by: Browning DJ, et al.
Published: (2016-04-01)

Anti-vascular endothelial growth factor treatment in diabetic macular edema
by: Kim M
Published: (2016-09-01)

Microinvasive pars plana vitrectomy combined with internal limiting membrane peeling versus anti-VEGF intravitreal injection for treatment-naïve diabetic macular edema (VVV-DME study): study protocol for a randomized controlled trial
by: Haoxin Guo, et al.
Published: (2023-10-01)

Two cases of diabetic macular edema complicated by an atypical macular hole
by: Yuich Yoshida, et al.
Published: (2020-04-01)

Glycemic Control after Initiation of Anti-VEGF Treatment for Diabetic Macular Edema
by: Hideyuki Oshima, et al.
Published: (2022-08-01)

Vitrectomy for macular edema due to retinal vein occlusion
by: Kumagai K, et al.
Published: (2019-06-01)

Changes of Optical Coherence Tomography Biomarkers in Macular Edema Secondary to Retinal Vein Occlusion After Anti-VEGF and Anti-Inflammatory Therapies
by: Ding X, et al.
Published: (2022-03-01)

Treatment of Macular Edema in Vascular Retinal Diseases: A 2021 Update
by: Andrzej Grzybowski, et al.
Published: (2021-11-01)

Effect of intravitreal dexamethasone on macular edema in von Hippel-Lindau disease assessed using swept-source optical coherence tomography: a case report
by: Angelo Maria Minnella, et al.
Published: (2018-09-01)

Visualization of changes in the foveal avascular zone in both observed and treated diabetic macular edema using optical coherence tomography angiography
by: Aditya Gill, et al.
Published: (2017-06-01)

Risperidone-related bilateral cystoid macular edema: a case report
by: Anna Kozlova, et al.
Published: (2019-03-01)

Undetectable Macular Neovascularization on OCT Angiography in Age Related Macular Degeneration: Comparison between Different Devices
by: Meryem Filali Ansary, et al.
Published: (2022-09-01)

The efficacy of micropulse laser combined with ranibizumab in diabetic macular edema treatment: study protocol for a randomized controlled trial
by: Xuejing Mi, et al.
Published: (2022-09-01)

Subthreshold micropulse laser versus intravitreal anti-VEGF for diabetic macular edema patients with relatively better visual acuity
by: Sezen Akkaya, et al.
Published: (2020-10-01)

Effect of intravitreal aflibercept on recalcitrant diabetic macular edema
by: Kendra A. Klein, et al.
Published: (2017-04-01)

Impact of treatment of diabetic macular edema on visual impairment in people with diabetes mellitus in India
by: Sucheta Kulkarni, et al.
Published: (2021-01-01)

Update on clinical characteristics and management of uveitic macular edema
by: Jyotirmay Biswas, et al.
Published: (2017-01-01)

Outcomes of pars plana vitrectomy for the treatment of persistent diffuse diabetic macular edema
by: Ashraf M Gad Elkareem, et al.
Published: (2018-01-01)

Assessment of the Macular Microvasculature in High Myopes With Swept Source Optical Coherence Tomographic Angiography
by: Chee-Wai Wong, et al.
Published: (2021-05-01)

Pars Plana Vitrectomy with Internal Limiting Membrane Peeling for Refractory Diffuse Diabetic Macular Edema
by: Mohammad-Hossein Dehghan, et al.
Published: (2010-01-01)

Choroidal thickness measured by swept source optical coherence tomography in diabetic macular edema
by: Haitham Y Al-Nashar, et al.
Published: (2020-01-01)

Involvement of Cytokines in the Pathogenesis of Diabetic Macular Edema
by: Hidetaka Noma, et al.
Published: (2021-03-01)

Increased risk of postsurgical macular edema in high stage idiopathic epiretinal membranes
by: Lorenzo Iuliano, et al.
Published: (2021-08-01)

Should we consider pars plana vitrectomy in the primary treatment of diabetic macular edema?
by: Lihteh Wu, et al.
Published: (2017-01-01)